NCT05731102

Brief Summary

The aims of this observational survey are to 1) collect data on the prevalence of mental and substance use disorders, and 2) investigate risk factors and consequences of mental and substance use disorder

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9,585

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 24, 2023

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

February 7, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 16, 2023

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2023

Completed
Last Updated

December 7, 2023

Status Verified

November 1, 2023

Enrollment Period

27 days

First QC Date

February 7, 2023

Last Update Submit

November 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of mental and substance use disorders

    Mental and substance use disorders assessed in standardised diagnostic interviews employing the Composite International Diagnostic Interview (CIDI 5.0). Diagnostic criteria after ICD-10 and DSM-5.

    January 2023 to February 2023

Secondary Outcomes (1)

  • The characteristics of nonparticipants in a psychiatric diagnostic survey

    January 2023 to February 2023

Interventions

Observational study assessing prevalence of mental and substance use disorders among college and university students

Eligibility Criteria

Age18 Years - 35 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsSexes Eligible for Study: All
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The base study population of the current study stem from the SHoT 2022 study, a large national survey of students enrolled in higher education in Norway. The SHoT 2022 was a comprehensive survey of several domains of mental health and lifestyle factors, distributed electronically through a web-based platform. In short, SHoT 2022 was conducted between February 8 and April 19, 2022, and invited all full-time Norwegian students pursuing higher education. In all, 169,572 students fulfilled the inclusion criteria, of whom 59,544 students completed the online questionnaires, yielding a response rate of 35.1%. When consenting to participate in the SHOT2022, the students were also asked to indicate if they wished be invited to a follow-up study of mental disorders, of whom 26,311 consented.

You may qualify if:

  • Being a fulltime college or university student
  • Norwegian citizenship
  • Ages 18-35 years
  • Sufficient understanding of Norwegian or English to conduct the interview

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norwegian Institute of Public Health

Bergen, 5000, Norway

Location

Related Publications (1)

  • Sivertsen B, Knudsen AKS, Kirkoen B, Skogen JC, Lagerstrom BO, Lonning KJ, Kessler RC, Reneflot A. Prevalence of mental disorders among Norwegian college and university students: a population-based cross-sectional analysis. Lancet Reg Health Eur. 2023 Sep 19;34:100732. doi: 10.1016/j.lanepe.2023.100732. eCollection 2023 Nov.

MeSH Terms

Conditions

Mental DisordersSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2023

First Posted

February 16, 2023

Study Start

January 24, 2023

Primary Completion

February 20, 2023

Study Completion

February 20, 2023

Last Updated

December 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

Researchers may gain access to participant data by contacting the SHOT publication committee. Approval from the Norwegian Regional Committee for Medical and Health Research Ethics is a pre-requirement. The SHOT dataset is administrated by the Norwegian Institute of Public Health.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
August 2023 to September 2030.
Access Criteria
Approval from the Norwegian Regional Committee for Medical and Health Research Ethics. The data must be stored in secure servers which require log in and from which no data can be extracted and copied.

Locations